Amyloid in endomyocardial biopsies

[1]  A. Aguzzi,et al.  Structural typing of systemic amyloidoses by luminescent-conjugated polymer spectroscopy. , 2010, The American journal of pathology.

[2]  H. R. Bergen,et al.  Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. , 2009, Blood.

[3]  M. Mihatsch,et al.  Prevalence and Origin of Amyloid in Kidney Biopsies , 2009, The American journal of surgical pathology.

[4]  J. Stone,et al.  Classification of amyloid deposits in diagnostic cardiac specimens by immunofluorescence. , 2009, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[5]  C. Röcken,et al.  Amyloidose in Leberbiopsien , 2009, Der Pathologe.

[6]  T. Todorov,et al.  Prevalence of Germline Mutations in the TTR Gene in a Consecutive Series of Surgical Pathology Specimens With ATTR Amyloid , 2009, The American journal of surgical pathology.

[7]  P. Westermark,et al.  Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis , 2008, The Journal of pathology.

[8]  K. Klingel,et al.  Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. , 2008, Journal of the American College of Cardiology.

[9]  C. Angermann,et al.  Kardiale Amyloidose , 2008, Medizinische Klinik.

[10]  H. Goldschmidt,et al.  Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[11]  F. Salvi,et al.  Gender-related risk of myocardial involvement in systemic amyloidosis , 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[12]  H. Kauczor,et al.  Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings , 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[13]  M. Picken.  New insights into systemic amyloidosis: the importance of diagnosis of specific type , 2007, Current opinion in nephrology and hypertension.

[14]  Keyur B Shah,et al.  Amyloidosis and the heart: a comprehensive review. , 2006, Archives of internal medicine.

[15]  C. Röcken,et al.  Immunohistochemical Classification of Amyloid in Surgical Pathology Revisited , 2006, The American journal of surgical pathology.

[16]  R. Falk.  Diagnosis and Management of the Cardiac Amyloidoses , 2005, Circulation.

[17]  U. Hellman,et al.  Amyloid deposits in transthyretin‐derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology , 2005, The Journal of pathology.

[18]  S. Ikeda.  Cardiac amyloidosis: heterogenous pathogenic backgrounds. , 2004, Internal medicine.

[19]  Richard E Thompson,et al.  Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. , 2004, Journal of the American College of Cardiology.

[20]  G. Holmgren,et al.  Hereditary transthyretin amyloidosis from a Scandinavian perspective , 2003, Journal of internal medicine.

[21]  Giampaolo Merlini,et al.  Molecular mechanisms of amyloidosis. , 2003, The New England journal of medicine.

[22]  K. Sletten,et al.  Amyloid in surgical pathology , 2003, Virchows Archiv.

[23]  A. Balduini,et al.  Serum N-Terminal Pro–Brain Natriuretic Peptide Is a Sensitive Marker of Myocardial Dysfunction in AL Amyloidosis , 2003, Circulation.

[24]  W. Saeger,et al.  The classification of amyloid deposits in clinicopathological practice , 1996, Histopathology.

[25]  M. Benson.  Hereditary amyloidosis and cardiomyopathy. , 1992, The American journal of medicine.

[26]  G. Baretton,et al.  [Systemic amyloidoses. Immunohistochemical typing at the time of autopsy using a series of specific antibodies]. , 1990, Der Pathologe.

[27]  A. Tajik,et al.  Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement. , 1988, Archives of internal medicine.

[28]  J. Hurlimann,et al.  Characterization of different amyloids with immunological techniques. , 1986, Pathology, research and practice.

[29]  R. Kyle,et al.  Clinical significance of histopathologic patterns of cardiac amyloidosis. , 1984, Mayo Clinic proceedings.

[30]  R. Falk,et al.  Amyloid heart disease. , 2010, Progress in cardiovascular diseases.

[31]  S. Kaul,et al.  Cardiac amyloidosis: new insights into diagnosis and management. , 2007, Reviews in cardiovascular medicine.

[32]  Walid M. Hassan,et al.  Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management. , 2005, Texas Heart Institute journal.

[33]  E. Gruys,et al.  Diagnosis of the type of amyloid in paraffin wax embedded tissue sections using antisera against human and animal amyloid proteins , 2004, Virchows Archiv A.

[34]  W. Saeger,et al.  Diagnosis and immunohistochemical classification of systemic amyloidoses. Report of 43 cases in an unselected autopsy series. , 1998, Virchows Archiv : an international journal of pathology.

[35]  J. Buxbaum,et al.  Transthyretin ILE20, a new variant associated with late‐onset cardiac amyloidosis , 1997, Human mutation.

[36]  W. Edwards,et al.  Amyloidosis and endomyocardial biopsy: Correlation of extent and pattern of deposition with amyloid immunophenotype in 100 cases. , 1995, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[37]  O. Eliseev.  [Cardiac amyloidosis]. , 1980, Terapevticheskii arkhiv.